- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: TRPV1.
Displaying page 1 of 1.
EudraCT Number: 2010-020944-37 | Sponsor Protocol Number: 09/0127 | Start Date*: 2011-10-31 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Pilot study to establish laboratory methods for urine Nerve Growth Factor (NGF) and immunohistochemical staining of the vanilloid receptor (TRPV1) in bladder biopsies, following open label treatmen... | |||||||||||||
Medical condition: Neurogenic & Idiopathic detrusor overactivity in the bladder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004994-25 | Sponsor Protocol Number: CSMS995A2101 | Start Date*: 2008-02-04 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multi-center, randomized, double-blind, placebo-controlled, crossover study in women with irritable bowel syndrome to evaluate feasibility and reproducibility of barostat assessments of colorecta... | |||||||||||||
Medical condition: Irritable Bowel Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004480-37 | Sponsor Protocol Number: SB-705498/008 | Start Date*: 2006-01-18 |
Sponsor Name:GlaxoSmithKline | ||
Full Title: A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute mig... | ||
Medical condition: acute migraine | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000306-36 | Sponsor Protocol Number: XEN-D0501-CL-04 | Start Date*: 2014-05-20 | |||||||||||
Sponsor Name:Xention Limited | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, crossover study to assess the efficacy of XEN D0501, a TRPV1 antagonist, in reducing the frequency of cough in patients with chronic idiopathic cough | |||||||||||||
Medical condition: Chronic Idiopathic Cough | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003976-20 | Sponsor Protocol Number: GRC6211-201 | Start Date*: 2007-09-12 | |||||||||||
Sponsor Name:GLENMARK PHARMACEUTICALS SA | |||||||||||||
Full Title: A randomised, double blind, placebo and active controlled, parallel group study to evaluate the analgesic effect of a single dose of GRC 6211, a TRPV1 receptor antagonist on pain following third... | |||||||||||||
Medical condition: treatment of pain following third molar extraction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004481-16 | Sponsor Protocol Number: VRA105345 | Start Date*: 2005-12-19 |
Sponsor Name:GlaxoSmithKline Research and Development | ||
Full Title: A multi-centre, randomised, single blind, placebo controlled, parallel group study to examine the effect of single doses of SB-705498, a TRPV1 receptor antagonist, on pain following third molar too... | ||
Medical condition: Dental pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002632-21 | Sponsor Protocol Number: VRA107438 | Start Date*: 2006-11-13 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development | |||||||||||||
Full Title: A double-blind, randomised, placebo controlled, single dose, two-period crossover study to investigate the therapeutic potential of the TRPV1 antagonist SB-705498 in treatment of subjects with rect... | |||||||||||||
Medical condition: Rectal Hyperalgesia (in patients with irritable bowel syndrome and feacal urgency) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018309-12 | Sponsor Protocol Number: 02-2010 | Start Date*: 2010-02-26 |
Sponsor Name:Association REDAR, Hôpital Ambroise Paré, Service d'Anesthésie et de Réanimation | ||
Full Title: Etude bi-centrique, randomisée, en groupes parallèles et double aveugle contre placebo pour évaluer l’efficacité et la sécurité à long terme de la toxine botulique en deux administrations répétées ... | ||
Medical condition: Painful peripheral neuropathies related to mononeuropathies (eg, traumatic, postherpetic...) or to polyneuropathies (eg, diabetic, idiopathic...) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021642-22 | Sponsor Protocol Number: VR1114693 | Start Date*: 2011-04-01 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A two part study to investigate the pharmacokinetics and pharmacodynamics of SB705498, a TRPV1 antagonist, in cough. Part A: an open label study in healthy subjects to determine the exposure to SB-... | |||||||||||||
Medical condition: Chronic cough | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004041-17 | Sponsor Protocol Number: XEN-D0501-CL-05 | Start Date*: 2013-12-13 | |||||||||||
Sponsor Name:Xention Limited | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, crossover study to assess the efficacy of XEN-D0501, a TRPV1 antagonist, in reducing the frequency of cough in patients with chronic obstructive pulm... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
